The association between pain and WHO grade of pancreatic neuroendocrine neoplasms: A multicenter study

被引:2
|
作者
Wang, Cheng [1 ,2 ]
Lin, Tingting [3 ]
Chen, Xin [4 ]
Cui, Wenjing [3 ]
Guo, Chuangen [5 ]
Wang, Zhongqiu [3 ]
Chen, Xiao [3 ]
机构
[1] Shanghai Inst Med Imaging, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Shanghai Med Coll, Dept Radiol, Shanghai, Peoples R China
[3] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Radiol, Nanjing 210029, Jiangsu, Peoples R China
[4] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Radiol, Shanghai, Peoples R China
[5] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Radiol, Hangzhou, Zhejiang, Peoples R China
关键词
Pancreatic neuroendocrine neoplasm; grade; pain; nomogram; clinical features; TUMORS; FEATURES; MANAGEMENT; NEUROPATHY;
D O I
10.3233/CBM-220080
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Abdominal or back pain is a common symptom in pancreatic diseases. However, the role of pain in pancreatic neuroendocrine neoplasm (PNENs) has not been clarified. OBJECTIVE: In this study, we aimed to show the association between the pain and the grade of PNENs. METHODS: A total of 186 patients with pathologically confirmed PNENs were included in this study. Clinical features and histological or radiological findings (size, location, and vascular invasion and local organs invasion and distal metastasis) were collected. Logistic regression analyses were used to show the association between pain and grade of PNENs. Nomogram was developed based on associated factors to predict the higher grade of PNENs. Receiver operating characteristic (ROC) curve was used to evaluate the diagnostic performance of size and nomogram model. RESULTS: The prevalence of pain in the cohort was 30.6% (n = 57). The vascular invasion and G3 PNENs were more common in the pain group (P = 0.02, P < 0.01). The tumor size was larger and incident of higher grade of PNENs was higher in the pain group than the non-pain group ( p < 0.01). Age, pain and size were independent risk factors for G2/G3 or G3 PNENs. The odds ratio was 3.03 (95% CI: 1.67-7.91) and 3.32 (95% CI: 1.42-7.79) for pain, respectively. The nomogram model was developed to predict the G2/G3 or G3 PNENs. The area under the curve (AUC) of the nomogram model was 0.84 (95% CI, 0.77-0.91) in predicting the G2/G3 PNENs, and was 0.84 (95% CI, 0.78-0.91) in predicting the G3 PNENs. CONCLUSION: Abdominal or back pain is associated with the grade of PNENs. The nomograms based on clinical features may be a powerful numerical tool for predicting the grade of PNENs. Keywords: Pancreatic neuroendocrine neoplasm, grade, pain, nomogram,
引用
收藏
页码:279 / 286
页数:8
相关论文
共 50 条
  • [21] Evaluation of ENETS and AJCC Staging Systems for Pancreatic Neuroendocrine Neoplasms: A Multicenter Study in China
    Jin, K.
    Zhang, Y.
    Luo, G.
    Sun, J.
    Tan, H.
    Li, J.
    Wang, W.
    Wang, W.
    Shao, C.
    Chen, J.
    Yu, X.
    NEUROENDOCRINOLOGY, 2016, 103 : 39 - 39
  • [22] Pancreatic Neuroendocrine Neoplasms: A Comparison of the WHO 2010 and 2017 Classifications
    Bal, Munita
    Sharma, Aishwarya
    Kumar, Rajiv
    Deodhar, Kedar
    Ramadwar, Mukta
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1632 - 1632
  • [23] Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review
    Chan, David L.
    Bergsland, Emily K.
    Chan, Jennifer A.
    Gadgil, Rujuta
    Halfdanarson, Thorvardur R.
    Hornbacker, Kathleen
    Kelly, Virginia
    Kunz, Pamela L.
    McGarrah, Patrick W.
    Raj, Nitya P.
    Reidy, Diane L.
    Thawer, Alia
    Whitman, Julia
    Wu, Linda
    Becker, Christoph
    Singh, Simron
    ONCOLOGIST, 2021, 26 (11): : 950 - 955
  • [24] Pancreatic Neuroendocrine Neoplasms: A Comparison of the WHO 2010 and 2017 Classifications
    Bal, Munita
    Sharma, Aishwarya
    Kumar, Rajiv
    Deodhar, Kedar
    Ramadwar, Mukta
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1632 - 1632
  • [25] Is the WHO 2010 classification system of pancreatic neuroendocrine neoplasms sufficient to clearly characterize pancreatic neuroendocrine carcinomas?
    Hijioka, Susumu
    Mizuno, Nobumasa
    Hara, Kazuo
    Imaoka, Hiroshi
    Yamao, Kenji
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 213 - 213
  • [26] Successful treatment of high-grade pancreatic neuroendocrine neoplasms with everolimus
    Genc, Cansu G.
    Klumpen, Heinz-Josef
    Denecke, Timm
    Wiedenmann, Bertram
    Pavel, Marianne
    ACTA ONCOLOGICA, 2018, 57 (05) : 686 - 688
  • [27] Well differentiated grade 3 pancreatic neuroendocrine tumors compared with related neoplasms: A morphologic study
    Sigel, Carlie S.
    Silva, Vitor Werneck Krauss
    Reid, Michelle D.
    Chhieng, David
    Basturk, Olca
    Sigel, Keith M.
    Daniel, Tanisha D.
    Klimstra, David S.
    Tang, Laura H.
    CANCER CYTOPATHOLOGY, 2018, 126 (05) : 326 - 335
  • [28] Neuroendocrine neoplasms of the breast: a multicenter retrospective Italian study
    Baldelli, Roberto
    Franco, Marta
    Renzelli, Valerio
    DE Fata, Riccardo
    Visca, Paolo
    Macciomei, Maria C.
    Fabi, Alessandra
    Rossi, Valentina
    Faggiano, Antongiulio
    Rizza, Laura
    Rota, Francesca
    Appetecchia, Marialuisa
    Vecchione, Andrea
    Lania, Andrea
    Antonini, Simone
    Botticelli, Andrea
    Verrico, Monica
    D'amati, Giulia
    Pignataro, Maria G.
    Cerbelli, Bruna
    Bianchi, Antonio
    LA Salvia, Anna
    Zuppi, Paolo
    Rindi, Guido
    MINERVA ENDOCRINOLOGY, 2024,
  • [29] Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms
    Crippa, S.
    Partelli, S.
    Boninsegna, L.
    Falconi, M.
    ANNALS OF ONCOLOGY, 2012, 23 (07) : 1928 - 1928
  • [30] Association between pathologic grade and multiphase computed tomography enhancement in pancreatic neuroendocrine neoplasm
    Kang, Jinwoo
    Ryu, Ji Kon
    Son, Jun Hyuk
    Lee, Jae Woo
    Choi, Jin Ho
    Lee, Sang Hyub
    Kim, Yong-Tae
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (09) : 1677 - 1682